Diabetic patients on Rutherford's stage 5 is the best indication of stem cell therapy in peripheral artery disease: A retrospective study on 367 patients

Stoltz, 2016, Stem cells and Vascular Regenerative medicine, a mini review, Clin Hemorheol Microcirc, 64, 613, 10.3233/CH-168036 Uccioli, 2015, Non-healing foot ulcers in diabetic patients: general and local interfering conditions and management options with advanced wound dressings, J Wound Care, 24, 35, 10.12968/jowc.2015.24.Sup4b.35 Hinchliffe, 2016, International Working Group on the Diabetic Foot, Effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review, Diabetes Metab Res Rev, 32, 136, 10.1002/dmrr.2705 Fanelli, 2013, Drug-eluting nitinol stent treatment of the superficial femoral artery and above-the-knee popliteal artery (the Zilver PTX single-arm clinical study): a comparison between diabetic and non diabetic patients, Cardiovasc Intervent Radiol, 36, 1232, 10.1007/s00270-012-0543-5 Buss, 2016, Guidance on the prevention of foot ulcers in at-risk patients with diabetes, Diabetes Metab Res Rev, 32, 16, 10.1002/dmrr.2696 Cavanagh, 2012, Cost of treating diabetic foot ulcers in five different countries, DiabMetab Res Rev, 28, 107, 10.1002/dmrr.2245 Prompers, 2008, Resource utilization and costs associated with the treatment of diabetic foot ulcers. Prospective data from the Eurodiale Study, Diabetologia, 51, 1826, 10.1007/s00125-008-1089-6 Wu, 2016, Mesenchymal stem cells as a prospective therapy for the diabetic foot, Stem Cell Int, 2016, 4612167 Cao, 2017, Mesenchymal stem cells improve healing of diabetic foot ulcer, J diabetes Res, 2017, 238, 10.1155/2017/9328347 Lehalle, 2015, Stem cells as a new treatment for peripheral artery disease: hype or hope?, Bio Med Mater Eng, 25, 73, 10.3233/BME-141229 Lu, 2011, Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial, Diabetes Res Clin Pract, 92, 26, 10.1016/j.diabres.2010.12.010 Huang, 2005, Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes, Diabetes Care, 28, 2155, 10.2337/diacare.28.9.2155 Kirana, 2012, Autologous stem cell therapy in treatment of limb ischemia induced chronic tissue ulcers of diabetic foot patients, Int J Clin Pract, 4, 384, 10.1111/j.1742-1241.2011.02886.x Mohammadzadeh, 2013, Therapeutic outcomes of transplanting autologous granulocyte colony-stimulating factor-mobilized peripheral mononuclear cells in diabetic patients with critical limb ischaemia, Exp Clin Endocrinol Diabetes, 1, 48 Ozturk, 2012, Therapeutical potential of autologous peripheral blood mononuclear cell transplantation in patients with type 2 diabetic critical limb ischemia, J Diabet Complicat, 1, 29, 10.1016/j.jdiacomp.2011.11.007 Qin, 2016, Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot, Exp Clin Endocrinol Diabetes, 124, 497, 10.1055/s-0042-103684 Zhang, 2017, Efficacy of cellular therapy for diabetic foot ulcer: a meta-analysis of randomized controlled clinical trials, Cell Transplant, 26, 1931, 10.1177/0963689717738013 Guo, 2017, Meta-analysis on the treatment of diabetic foot ulcers with autologous stem cells, Stem Cell Res Ther, 8, 228, 10.1186/s13287-017-0683-2